The Oncopole of Toulouse has a strong international focus. In fact, the Oncopole of Toulouse Association is firmly committed to developing partnerships and exchanges with its foreign counterparts in cutting-edge fields and already has direct and indirect agreements with Europe (Great Britain and Spain), Russia, China and Canada.
Several cooperative agreements are underway involving partners such as the Inserm, the GSO, and others.
- The United Kingdom (INSERM)
There are many agreements between Toulouse laboratories and universities and their international counterparts such as “The Toulouse Dundee Alliance against cancer”. This alliance has resulted in the creation of a joint research laboratory including the Inserm, the University of Toulouse 3, and the University of Dundee in cooperation with Cancer Research UK. In March 2006, the first meeting to celebrate this alliance was held in Toulouse. The collaborative project between Dundee and Toulouse has fostered exchanges between researchers and clinical practitioners from the two teams and is based on a research project that is both fundamental and clinical in scope.
The Oncopole of Toulouse will implement more global cooperative agreements such as the partnership agreement signed with Russia even before the operational opening of the site.
Hence, the Oncopole of Toulouse will work in collaboration with the Oncology Research Center in Blokhine from the Academy of Medical Sciences of Russia in Moscow. This collaboration is an integral part of the global cooperative plan against cancer between France and Russia via the National Cancer Institute. The two countries have set up national and regional organizations to promote the excellence of clinical care and scientific research.
- China (Oncopole of Toulouse Association and competitive cluster)
In March 2007 and in September 2010, a cooperation memorandum was signed between “Le Grand Capital Cancer Union (GCCU)” and the Life Sciences Park in Pekin. This cooperative venture should encourage scientific exchanges, development of common projects and links with the private sector.
A similar agreement is underway with the « Cancerboard » of Alberta, Canada.
Already diverse actors from the Toulouse Cancer field and in particular the Claudius Regaud Institute participate in the scientific committee of the Alberta Cancer Board and its prevention committee. Teams from the University of Alberta have shown interest in the form of governance and organizational/scientific aspects of the Oncopole of Toulouse.
- Spain (GIP GSO)
An agreement has already been signed between Le Cancéropôle grand-Sud-ouest (GSO Canceropole) and Spain. In 2006, a scientific collaborative agreement was signed between the GSO Canceropole and le "Centro Nacional de Investigaciones Oncologicas" (CNIO) and l’Institut National du Cancer (INCa). This collaboration concerns several key research areas under the aegis of the Oncopole of Toulouse and three Toulouse based teams are already involved in the project.
A relationship already exists with Catalonia in the field of oncology including industrial partnerships such as with Pierre Fabre.